| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 18.453 | 3.824 | 5.298 | 4.400 | 581 |
| Total Income - EUR | - | - | - | - | 0 | 18.453 | 3.824 | 5.298 | 4.400 | 581 |
| Total Expenses - EUR | - | - | - | - | 222 | 8.919 | 2.132 | 383 | 734 | 2.845 |
| Gross Profit/Loss - EUR | - | - | - | - | -222 | 9.535 | 1.691 | 4.915 | 3.666 | -2.264 |
| Net Profit/Loss - EUR | - | - | - | - | -222 | 9.036 | 1.656 | 4.756 | 3.080 | -2.264 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Beta Therra-Pi S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 44 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 325 | 8.899 | 4.611 | 4.952 | 7.983 | 5.594 |
| Inventories | - | - | - | - | 143 | 141 | 137 | 138 | 137 | 137 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 0 | 52 | 332 |
| Cash | - | - | - | - | 181 | 8.759 | 4.473 | 4.814 | 7.794 | 5.125 |
| Shareholders Funds | - | - | - | - | -180 | 8.859 | 4.574 | 4.797 | 7.902 | 5.594 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 81 | 80 |
| Debts | - | - | - | - | 548 | 40 | 37 | 155 | 81 | 0 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
5520
|
|||||||||
Comments - Beta Therra-Pi S.r.l.